Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accrual, Acea, Addendum, aid, Allerton, Alumni, attorney, Autilion, AutilionFinancing, Avenue, Bayside, benchmark, benchmarking, Bergamo, Bioresearch, breakthrough, broader, cardiomyocyte, Carlo, CCRM, confidence, consortium, contractile, Covenant, cryopreserved, cytochrome, deadline, decade, Descue, designee, Dillon, dramatically, electrical, environment, enzyme, era, Excalber, exemplary, expasion, exploratory, extraordinary, Feb, figure, fluorescence, fold, footnote, formidable, fundamental, GE, GmbH, GSK, hBLA, healing, hepatic, hereof, hESC, HIV, hPSC, immune, induction, isoform, IVT, JD, Joinder, KG, landmark, lawfully, live, Lonza, mandatorily, marrow, McMaster, merged, methodology, metric, Monte, mRNA, native, NEPA, Nobel, omitted, OMX, ourresearch, page, paradigm, Park, passed, patch, Ph, pinpoint, poor, predominant, problem, Progressive, proof, propagation, PTE, qualification, ratifying, regenerate, reissuance, remarkable, repopulate, reset, restoration, rifampicin, SCRA, settlement, shift, showed, signal, signature, simulation, solid, Sorted, sorting, stead, steroid, strong, subcontract, subfamily, Subscription, substitute, substitution, surface, talent, TET, thereunto, therewith, thing, tool, trechnology, true, Trust, unaffiliated, unamortized, unqualified, unregistered, unsorted, untranslated, urea, vacate, version, Waiver, WHEREOF, Wisconsin
Filing tables
Filing exhibits
- 10-K Annual report
- 10.81 Assignment and Assumption Agreement Between Autilion Ag and Bergamo Acquisition Corp Pte LTD Dated April 12, 2013
- 10.83 Lease Between Bayside Area Development LLC and Vistagen Therapeutics, Inc. (California) Dated April 24, 2013
- 10.84 Indemnification Agreement Effective May 20, 2013 Between the Company and Jon S. Saxe
- 10.85 Indemnification Agreement Effective May 20, 2013 Between the Company and Shawn K. Singh
- 10.86 Indemnification Agreement Effective May 20, 2013 Between the Company and H. Ralph Snodgrass
- 10.87 Indemnification Agreement Effective May 20, 2013 Between the Company and Brian J. Underdown
- 10.88 Indemnification Agreement Effective May 20, 2013 Between the Company and Jerrold D. Dotson
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32 EX-32
VTGN similar filings
Filing view
External links
EXHIBIT 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of VistaGen Therapeutics, Inc. (the “ Company ”) hereby certifies, to such officer’s knowledge, that:
(i) the accompanying Annual Report on Form 10-K of the Company for the annual period ended March 31, 2013 (the “ Report ”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
July 18, 2013
/s/ Shawn K. Singh
Shawn K. Singh, JD
Principal Executive Officer
/s/ Jerrold D. Dotson
Jerrold D. Dotson
Principal Financial Officer